Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience accelerated progression of presbyopia
- 1404/9/5
- more...
Company Info
Salamat Sazan Pars Buali Pharmaceutical Manufacturer of Eye Drop and Nasal Spray Products and Prefilled Syringes- PBA Pharma
Organization policy
Manufacturing products with the best raw materials and high quality to ensure the effectiveness and safety of medicine
Products
- Multidose Eye-Drops
- Nasal Sprays
- Prefilled Syringes
- HTK Solution
Management:
The board of directors of the company are made up of famous professors and specialists of the country with more than 30 years of experience in the field of drug import.
Betavision - PBA
Corticosteroid
Dorzomol - PBA
Increased eye pressure
Prostovision - PBA
Multidose Eye Drops
Optotim – PBA
Increased eye pressure
Trusovision – PBA
Increased eye pressure
Lacrivision - PBA
Artificial tears
Alfavision – PBA
Increased eye pressure
Xalavision-PBA
Increased eye pressure
Patavision - PBA
Ophthalmic antihistamine
Levovision-PBA
Antibiotics
Metholovision - PBA
Corticosteroid
Tearvision - PBA
artificial tears
Polylubran - PBA
artificial tears
Dorzomol - PBA Preservative Free
Increased eye pressure
Bimatoprost - PBA
Increased eye pressure
Alastinase - PBA
Nasal Sprays
Ipratronex - PBA
Nasal Sprays
Ipratronex - PBA
Nasal Sprays
Cortoflo - PBA
Nasal Sprays
Mometanase - PBA
Nasal Sprays
Allergomist - PBA
Nasal Sprays
Clenoxan - PBA
Prefilled Syringes
Cortobudenase - PBA
Nasal Sprays
Custo-Graft- PBA
HTK Solution
Brinovision - PBA
Increased eye pressure
Coxalavision - PBA
Increased eye pressure
Opticopred - PBA
Corticosteroid
Lotevision - PBA
Corticosteroid
The Production line of Salamat Sazan Pars Buali Pharmaceutical Company
In the following two videos, you can see a part of the process of producing different types of drugs at the Salamat Sazan Pars Buali Factory, which is located in the special economic zone of Shiraz, and also a part of the opening ceremony of this factory.
The first phase of the production line of Salamat Sazan Pars Buali Factory includes the production of multi-dose eye drops, multi-dose eye drops without preservatives, nasal sprays and pre-filled syringes by advanced and up-to-date equipment and devices prepared from European countries such as Italy. Spain and Germany. A part of the opening ceremony of this factory can be seen in the video below
The opening ceremony of Salamat Sazan Pars Buali pharmaceutical company was attended by the Honorable Deputy Minister and the Honorable Head of the Food and Drug Organization (Mr. Dr. Mohammadi), the Director General of Medicines and Controlled Substances (Mr. Dr. Pikanpour), the Honorable Governor of Fars (Mr. Dr. Imanieh) ) and professors, managers and experts of the country and Fars province in February 1401
About Us
Salamat Sazan Pars Buali Pharmaceutical Company is the manufacturer of pharmaceutical products with a collection of ophthalmic drugs, nasal sprays and pre-filled syringes from the first production sets of high-tech drugs and multi-dose preservatives free eye drops in the south of the country with the GMP certificate from the Food and Drug Organization using high quality raw materials from reliable European sources.
Eye Health Information and News
A 15-year-old boy developed myopia at 8 years and was treated with 0.01% atropine daily in both eyes. The atropine dose was increased yearly as the myopia progressed.
- 1404/8/29
- more...
The challenge is to identify drugs and associated substances that do not cause adverse effects or complications in pediatric patients with GDD implants.
- 1404/8/19
- more...
EyeCool Therapeutics Announces Results of Pilot Study of Novel Chronic Ocular Surface Pain Treatment
Clinical-stage medical technology company EyeCool Therapeutics, based in Cambridge, Massachusetts, has announced positive results from a pilot study on its investigational ETX-4143 device for the treatment of chronic ocular surface pain (COSP).
- 1404/6/15
- more...
A research team from Turkey, led by Dr. Oğuzhan Kılıçarslan (FEBO, FICO), has reported that COVID-19 affects the morphology of corneal endothelial cells in patients with ocular symptoms.
- 1404/6/6
- more...
A new study shows that Paclitaxel, a drug used for the treatment of breast cancer, can, in very rare cases, cause a serious complication known as Central Retinal Artery Occlusion (CRAO)....
- 1404/6/5
- more...
Chinese researchers have demonstrated that repeated low-level red light (RLRL) therapy can effectively control the progression of myopia in children.
- 1404/5/30
- more...
For many years, topical antibiotics have been administered perioperatively in cataract surgery to prevent endophthalmitis....
- 1404/5/16
- more...
Up to Date Technology
All the products of Salamat Sazan Pars Bouali pharmaceutical company are manufactured by equipment and devices from European countries such as Italy, Spain and Germany.